keyword
https://read.qxmd.com/read/38491532/trastuzumab-in-patients-with-breast-cancer-and-pre-existing-left-ventricular-systolic-dysfunction
#41
JOURNAL ARTICLE
Azin Alizadehasl, Mina Mohseni, Kamran Roudini, Parisa Firoozbakhsh
BACKGROUND: Trastuzumab is one of the most effective treatments in HER-2 positive breast cancer patients. However, it is associated with development of cardiomyopathy/heart failure (HF) which is often a limiting side effect and associated with overall adverse outcomes. As a result, patients with pre-existing LV systolic dysfunction (LVSD) are often excluded from receiving anti-HER-2 therapy, which may lead to less effective cancer treatment and worse prognosis. OBJECTIVES: The current study aims to evaluate the safety of trastuzumab in patients with HER-2 positive breast cancer and pre-existing LVSD...
March 15, 2024: Cardio-Oncology
https://read.qxmd.com/read/38488036/doxorubicin%C3%A2-induced-cardiomyopathy-is-mitigated-by-empagliflozin-via-the-modulation-of-endoplasmic-reticulum-stress-pathways
#42
JOURNAL ARTICLE
Akshi Malik, Ashim K Bagchi, Davinder S Jassal, Pawan K Singal
Doxorubicin (Dox) exhibits a high efficacy in the treatment of numerous types of cancer. However, the beneficial cytotoxic effects of Dox are often accompanied by an increase in the risk of cardiotoxicity. Oxidative stress (OS) plays a key role in Dox‑induced cardiomyopathy (DIC). OS in cardiomyocytes disrupts endoplasmic reticulum (ER) function, leading to the accumulation of misfolded/unfolded proteins known as ER stress. ER stress acts as an adaptive mechanism; however, prolonged ER stress together with OS may lead to the initiation of cardiomyocyte apoptosis...
May 2024: Molecular Medicine Reports
https://read.qxmd.com/read/38482205/immunotherapy-associated-cardiovascular-toxicities-insights-from-preclinical-and-clinical-studies
#43
REVIEW
Youqian Kong, Xiaoyu Wang, Rui Qie
Immune checkpoint inhibitors (ICIs) have become a widely accepted and effective treatment for various types of solid tumors. Recent studies suggest that cardiovascular immune-related adverse events (irAEs) specifically have an incidence rate ranging from 1.14% to more than 5%. Myocarditis is the most common observed cardiovascular irAE. Others include arrhythmias, pericardial diseases, vasculitis, and a condition resembling takotsubo cardiomyopathy. Programmed cell death-1 (PD-1)/programmed cell death ligand-1 (PD-L1) pathway, cytotoxic T-lymphocyte antigen-4 (CTLA-4) pathway, and the recently discovered lymphocyte-activation gene 3 (LAG-3) pathway, play a critical role in boosting the body's natural immune response against cancer cells...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38474123/early-impairment-of-paracrine-and-phenotypic-features-in-resident-cardiac-mesenchymal-stromal-cells-after-thoracic-radiotherapy
#44
JOURNAL ARTICLE
Vittorio Picchio, Roberto Gaetani, Francesca Pagano, Yuriy Derevyanchuk, Olivia Pagliarosi, Erica Floris, Claudia Cozzolino, Giacomo Bernava, Antonella Bordin, Filipe Rocha, Ana Rita Simões Pereira, Augusto Ministro, Ana Teresa Pinto, Elena De Falco, Gianpaolo Serino, Diana Massai, Radia Tamarat, Maurizio Pesce, Susana Constantino Rosa Santos, Elisa Messina, Isotta Chimenti
Radiotherapy-induced cardiac toxicity and consequent diseases still represent potential severe late complications for many cancer survivors who undergo therapeutic thoracic irradiation. We aimed to assess the phenotypic and paracrine features of resident cardiac mesenchymal stromal cells (CMSCs) at early follow-up after the end of thoracic irradiation of the heart as an early sign and/or mechanism of cardiac toxicity anticipating late organ dysfunction. Resident CMSCs were isolated from a rat model of fractionated thoracic irradiation with accurate and clinically relevant heart dosimetry that developed delayed dose-dependent cardiac dysfunction after 1 year...
March 1, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38467416/longitudinal-adherence-to-surveillance-for-late-effects-of-cancer-treatment-a-population-based-study-of-adult-survivors-of-childhood-cancer
#45
JOURNAL ARTICLE
Jennifer Shuldiner, Rinku Sutradhar, Cindy Lau, Nida Shah, Emily Lam, Noah Ivers, Paul C Nathan
BACKGROUND: Adult survivors of childhood cancer are at elevated risk of morbidity and mortality compared to the general population, but their adherence to lifelong periodic surveillance is suboptimal. We aimed to examine adherence to surveillance guidelines for high-yield tests and identify risk factors for nonadherence in adult survivors of childhood cancer. METHODS: In this retrospective, population-based cohort study, we used health care administrative data from Ontario, Canada, to identify adult survivors of childhood cancer diagnosed between 1986 and 2014 who were at elevated risk of therapy-related colorectal cancer, breast cancer, or cardiomyopathy...
March 10, 2024: Canadian Medical Association Journal: CMAJ
https://read.qxmd.com/read/38460862/meteorin-like-metrnl-attenuates-hypertensive-induced-cardiac-hypertrophy-by-inhibiting-autophagy-via-activating-brca2
#46
JOURNAL ARTICLE
Jun Li, Yinghui Hong, Yinsheng Zhong, Shujun Yang, Liying Pei, Zijie Huang, Huibao Long, Xuxiang Chen, Changqing Zhou, Guanghui Zheng, Chaotao Zeng, Haidong Wu, Tong Wang
Hypertension, a prevalent cardiovascular ailment globally, can precipitate numerous complications, notably hypertensive cardiomyopathy. Meteorin-like (METRNL) is demonstrated to possess potential protective properties on cardiovascular diseases. However, its specific role and underlying mechanism in hypertensive myocardial hypertrophy remain elusive. Spontaneously hypertensive rats (SHRs) served as hypertensive models to explore the effects of METRNL on hypertension and its induced myocardial hypertrophy. The research results indicate that, in contrast to Wistar-Kyoto (WKY) rats, SHRs exhibit significant symptoms of hypertension and myocardial hypertrophy, but cardiac-specific overexpression (OE) of METRNL can partially ameliorate these symptoms...
March 7, 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38456890/obesity-predisposes-anthracycline-treated-survivors-of-childhood-and-adolescent-cancers-to-subclinical-cardiac-dysfunction
#47
JOURNAL ARTICLE
Ian A George, BriAnna Souder, Amy Berkman, David H Noyd, M Jay Campbell, Piers C A Barker, Michael Roth, Michelle A T Hildebrandt, Kevin C Oeffinger, Andrew W McCrary, Andrew P Landstrom
Anthracyclines are effective chemotherapeutics used in approximately 60% of pediatric cancer cases but have a well-documented risk of cardiotoxicity. Existing cardiotoxicity risk calculators do not include cardiovascular risk factors present at the time of diagnosis. The goal of this study is to leverage the advanced sensitivity of strain echocardiography to identify pre-existing risk factors for early subclinical cardiac dysfunction among anthracycline-exposed pediatric patients. We identified 115 pediatric patients with cancer who were treated with an anthracycline between 2013 and 2019...
March 8, 2024: Pediatric Cardiology
https://read.qxmd.com/read/38432878/role-of-danggui-buxue-decoction-for-the-prevention-and-treatment-of-cardiovascular-and-pulmonary-diseases
#48
JOURNAL ARTICLE
Lin Jiang, Liping Chen, Wenbin Li, Rong Wang
Cardiovascular and pulmonary diseases have become the major disease endangering people's physical and mental health because of its high morbidity and mortality. Danggui Buxue Decoction, a noteworthy classical prescription, is composed of astragali radix and angelicae sinensis radix at a ratio of 5꞉1. It is a prescription for tonifying both vital energy and blood and has the effect of dredging collaterals. Its main active components, such as polysaccharides, saponins, flavonoids and volatile oils, have good effects on antioxidation, inflammation regulation, immune regulation and promotion of blood circulation...
October 28, 2023: Zhong Nan da Xue Xue Bao. Yi Xue Ban, Journal of Central South University. Medical Sciences
https://read.qxmd.com/read/38432632/high-throughput-virtual-search-of-small-molecules-for-controlling-the-mechanical-stability-of-human-cd4
#49
JOURNAL ARTICLE
Antonio Reifs, Alba Fernandez-Calvo, Borja Alonso-Lerma, Jörg Schönfelder, David Franco, Mariano Ortega-Muñoz, Salvador Casares, Concepcion Jimenez-Lopez, Laura Saa, Aitziber L Cortajarena, David De Sancho, Eider San Sebastian, Raul Perez-Jimenez
Protein mechanical stability determines the function of a myriad of proteins, especially proteins from the extracellular matrix. Failure to maintain protein mechanical stability may result in diseases and disorders such as cancer, cardiomyopathies, or muscular dystrophy. Thus, developing mutation-free approaches to enhance and control the mechanical stability of proteins using pharmacology-based methods, may have important implications in drug development and discovery. Here, we present the first approach that employs computational High-Throughput Virtual Screening (HTVS) and Molecular Docking to search for small-molecules in chemical libraries that function as mechano-regulators of the stability of human CD4, receptor of HIV-1...
March 1, 2024: Journal of Biological Chemistry
https://read.qxmd.com/read/38428902/remimazolam-based-anesthesia-in-a-patient-with-hypertrophic-obstructive-cardiomyopathy-undergoing-radical-colorectal-cancer-surgery-a-case-report
#50
JOURNAL ARTICLE
Yongchang Shi, Chengchao Zuo, Yiwen Zhang, Chao Zhou, Fengjiao Zhang, Xuelian Zhao
BACKGROUND: The goal of anesthesia in patients with hypertrophic obstructive cardiomyopathy (HOCM) is to reduce the risk of left ventricular outflow tract obstruction triggered by anesthetics. Remimazolam is a newly developed anesthetic that has been reported to have superior hemodynamic stability. There have been no reports on the completion of non-cardiac surgery with remimazolam in patients with HOCM. METHODS: Here we report the case of a 49-year-old man diagnosed with hypertrophic obstructive cardiomyopathy who underwent resection of colon cancer with remimazolam and remifentanil anesthesia...
March 1, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38395903/protocol-for-the-onloop-trial-pragmatic-randomized-trial-evaluating-a-province-wide-system-of-personalized-reminders-for-evidence-based-surveillance-tests-in-adult-survivors-of-childhood-cancer-in-ontario
#51
JOURNAL ARTICLE
Jennifer Shuldiner, Emily Lam, Nida Shah, Jeremy Grimshaw, Laura Desveaux, Ruth Heisey, Michael S Taccone, Monica Taljaard, Kednapa Thavorn, David Hodgson, Sumit Gupta, Aisha Lofters, Noah Ivers, Paul C Nathan
BACKGROUND: Childhood cancer treatment while often curative, leads to elevated risks of morbidity and mortality. Survivors require lifelong periodic surveillance for late effects of treatment, yet adherence to guideline-recommended tests is suboptimal. We created ONLOOP to provide adult survivors of childhood cancer with detailed health information, including summaries of their childhood cancer treatment and recommended surveillance tests for early detection of cardiomyopathy, breast cancer, and/or colorectal cancer, with personalized reminders over time...
February 23, 2024: Implementation Science: IS
https://read.qxmd.com/read/38385137/a-prospective-randomized-controlled-trial-to-determine-the-safety-and-efficacy-of-extracorporeal-shock-waves-therapy-for-primary-prevention-of-subclinical-cardiotoxicity-in-breast-cancer-patients-without-a-cardiovascular-risk-treated-with-doxorubicin
#52
JOURNAL ARTICLE
Shinjeong Song, Joohyun Woo, HyunGoo Kim, Jun Woo Lee, Woosung Lim, Byung-In Moon, Kihwan Kwon
BACKGROUND: Doxorubicin is a highly effective anti-cancer drug that causes left ventricular (LV) dysfunction and induces late-onset cardiomyopathy. However, an effective and clinically applicable preventive treatment is yet to be discovered. OBJECTIVE: Cardiac-Extracorporeal shockwave therapy (C-ESWT) has been suggested to treat inflammatory and ischemic diseases and protect cardiomyocytes from doxorubicin-induced cardiomyopathy. This study aims to assess the safety and efficacy of C-ESWT in the prevention of subclinical cardiotoxicity...
2024: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/38377826/the-role-of-hydrogen-sulfide-regulation-of-pyroptosis-in-different-pathological-processes
#53
REVIEW
Yanting Zhang, Huijie Zhao, Xiaodi Fu, Kexiao Wang, Jiahao Yang, Xinyuan Zhang, Honggang Wang
Pyroptosis is one kind of programmed cell death in which the cell membrane ruptures and subsequently releases cell contents and pro-inflammatory cytokines including IL-1β and IL-18. Pyroptosis is caused by many types of pathological stimuli, such as hyperglycemia (HG), oxidative stress, and inflammation, and is mediated by gasdermin (GSDM) protein family. Increasing evidence indicates that pyroptosis plays an important role in multiple diseases, such as cancer, kidney diseases, inflammatory diseases, and cardiovascular diseases...
February 16, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38375475/immune-checkpoint-inhibitors-associated-cardiovascular-immune-related-adverse-events
#54
REVIEW
Wonyoung Jo, Taejoon Won, Abdel Daoud, Daniela Čiháková
Immune checkpoint inhibitors (ICIs) are specialized monoclonal antibodies (mAbs) that target immune checkpoints and their ligands, counteracting cancer cell-induced T-cell suppression. Approved ICIs like cytotoxic T-lymphocyte antigen-4 (CTLA-4), programmed death-1 (PD-1), its ligand PD-L1, and lymphocyte activation gene-3 (LAG-3) have improved cancer patient outcomes by enhancing anti-tumor responses. However, some patients are unresponsive, and others experience immune-related adverse events (irAEs), affecting organs like the lung, liver, intestine, skin and now the cardiovascular system...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38350635/from-hypertension-to-beyond-unraveling-the-diverse-mechanisms-of-olmesartan-in-disease-modulation
#55
JOURNAL ARTICLE
Laiba Rind, Tarique Mahmood, Mohammed Haris Siddiqui, Farogh Ahsan, Arshiya Shamim, Aamir Anwar, Rajnish Kumar Yadav
Olmesartan, originally known for its antihypertensive properties, exhibits promising potential in addressing inflammation-mediated diseases. As an angiotensin II receptor blocker (ARB), Olmesartan influences pivotal pathways, including reactive oxygen species, cytokines, NF-κB, TNF-α, and MAPK. This suggests a viable opportunity for repurposing the drug in conditions such as ulcerative colitis, neuropathy, nephropathy, and cancer, as supported by multiple preclinical studies. Ongoing clinical trials, particularly in cardiomyopathy and nephropathy, suggest a broader therapeutic scope for Olmesartan...
March 2024: Drug Research
https://read.qxmd.com/read/38340258/utility-of-apical-four-chamber-longitudinal-strain-in-the-assessment-of-childhood-cancer-survivors-a-multicenter-study
#56
JOURNAL ARTICLE
Matthew J Mosgrove, Ritu Sachdeva, Kayla L Stratton, Saro H Armenian, Aarti Bhat, Kasey J Leger, Christina Yang, Wendy M Leisenring, Lillian R Meacham, Karim T Sadak, Shanti L Narasimhan, Paul C Nathan, Eric J Chow, William L Border
BACKGROUND: A previous multicenter study showed that longitudinal changes in standard cardiac functional parameters were associated with the development of cardiomyopathy in childhood cancer survivors (CCS). Evaluation of the relationship between global longitudinal strain (GLS) changes and cardiomyopathy risk was limited, largely due to lack of quality apical 2- and 3-chamber views in addition to 4-chamber view. We sought to determine whether apical 4-chamber longitudinal strain (A4LS) alone can serve as a suitable surrogate for GLS in this population...
February 2024: Echocardiography
https://read.qxmd.com/read/38329404/assessment-of-feasibility-and-interscan-variability-of-short-time-cardiac-mri-for-cardiotoxicity-evaluation-in-breast-cancer
#57
JOURNAL ARTICLE
Yoo Jin Hong, Kyunghwa Han, Hye-Jeong Lee, Jin Hur, Young Jin Kim, Min Jung Kim, Byoung Wook Choi
Purpose To investigate the feasibility and interscan variability of short-time cardiac MRI protocol after chemotherapy in individuals with breast cancer. Materials and Methods A total of 13 healthy female controls (mean age, 52.4 years ± 13.2 [SD]) and 85 female participants with breast cancer (mean age, 51.8 years ± 9.9) undergoing chemotherapy prospectively underwent routine breast MRI and short-time cardiac MRI using a 3-T scanner with peripheral pulse gating in the prone position. Interscan, intercoil, and interobserver reproducibility and variability of native T1 and extracellular volume (ECV), as well as ventricular functional parameters, were measured using the intraclass correlation coefficient (ICC), standard error of measurement (SEM), or coefficient of variation (CoV)...
February 2024: Radiology. Cardiothoracic imaging
https://read.qxmd.com/read/38328601/early-use-of-intrapartum-intra-aortic-balloon-pump-support-for-haemodynamic-stabilization-of-peripartum-and-anthracycline-induced-cardiomyopathy-a-case-report
#58
Karthic Chandran, Donald Quimby, Hiram G Bezerra, Daniela Crousillat
BACKGROUND: Prior exposure to cardiotoxic cancer therapies has been associated with an increased risk of peripartum cardiomyopathy (PPCM). The management of PPCM in this population remains a clinical challenge. Few studies have explored the use of mechanical circulatory support in PPCM. We present a case of early implementation of intra-aortic balloon pump (IABP) therapy for acute stabilization and intrapartum support of PPCM. CASE SUMMARY: A 36-year-old G4P2103 (4th pregnancy, two full-term, one premature birth, 0 abortions, and three living children) woman at 26 weeks and 5 days gestation with history of combined peripartum and anthracycline-induced cardiomyopathy [previously left ventricular ejection fraction (LVEF) 10-15% and recently 40-45%] presented with acute decompensated heart failure...
February 2024: European Heart Journal. Case Reports
https://read.qxmd.com/read/38309931/cardiotoxicity-risk-of-cancer-treatment-in-patients-with-underlying-cardiomyopathies-is-hypertrophic-cardiomyopathy-any-different
#59
EDITORIAL
Muhannad Aboud Abbasi, Edward El-Am, Jeffrey B Geske, Joerg Herrmann
No abstract text is available yet for this article.
February 2024: Mayo Clinic Proceedings
https://read.qxmd.com/read/38309590/-inherited-cardiovascular-disease-mindset-can-identify-concealed-inherited-conditions-at-cardio-oncology-evaluation-an-opportunistic-screening
#60
JOURNAL ARTICLE
Rebeca Lorca, María Fernández, Pablo Avanzas, Isaac Pascual, Rut Álvarez-Velasco, Iria Silva, Luis Gutiérrez, Juan Gómez, María Muñiz, Carlos Álvarez, Emilio Esteban, Teresa López-Fernández
INTRODUCTION: Baseline cardiovascular (CV) risk stratification is recommended in all cancer patients. Integrating all clinical information (personal/family history, ECG and echocardiogram) can properly identify high-risk patients. We aimed to evaluate the concealed inherited CV conditions detected in mandatory CV screening performed at a Cardio-Oncology Unit. METHODS: retrospective study of all consecutive cancer patients referred to the Cardio-Oncology Unit for CV evaluation (2020-2023)...
February 1, 2024: International Journal of Cardiology
keyword
keyword
19632
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.